Chargement en cours...
Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer
BACKGROUND: Ampulla of Vater cancer (AoV Ca) is a rare tumor, and its adjuvant treatment has not been established. The purpose of this study was to find out prognostic factors including host immunity and role of adjuvant treatment in AoV Ca. METHODS AND FINDINGS: We reviewed 227 AoV Ca patients with...
Enregistré dans:
| Publié dans: | PLoS One |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4790941/ https://ncbi.nlm.nih.gov/pubmed/26974670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0151406 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|